 MARSEILLE, France, Nov. 17, 2020 GLOBE NEWSWIRE -- Innate Pharma SA Euronext Paris: IPH ISIN: FR0010331421; Nasdaq: IPHA Innate or the Company today announced its revenues and cash position for the first nine months of 2020. 